• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

主结节的组织病理学分化决定了同步多中心肝细胞癌肝切除术后的预后。

Histopathologic differentiation of the main nodule determines outcome after hepatic resection for synchronous multicentric hepatocellular carcinomas.

作者信息

Ariizumi Shun-ichi, Takasaki Ken, Yamamoto Masakazu, Ohtsubo Takehito, Katsuragawa Hideo, Katagiri Satoshi

机构信息

Department of Surgery, Institute of Gastroenterology, Tokyo Women's Medical University, Tokyo, Japan.

出版信息

Hepatogastroenterology. 2004 Mar-Apr;51(56):500-4.

PMID:15086191
Abstract

BACKGROUND/AIMS: Clinicopathological features and outcome after surgery in patients with synchronous multicentric hepatocellular carcinoma were examined in relation to the histopathological grade of differentiation of the main nodule.

METHODOLOGY

Two hundred and sixty-five patients with synchronous multicentric hepatocellular carcinoma (total, 683 nodules) who had undergone curative hepatectomy from 1988 through 1999 were studied retrospectively. In multicentric occurrences of hepatocellular carcinoma, the tumor with the largest dimension was defined as the main nodule, and the others as accessory nodules.

RESULTS

The histopathological grade of differentiation of the main nodule was assessed to be well differentiated in 72 patients (27.2%), moderately differentiated in 160 patients (60.4%), and poorly differentiated in 33 patients (12.4%). Tumor size of the main nodule was significantly smaller in patients with well differentiated hepatocellular carcinoma than in patients with moderately or poorly differentiated hepatocellular carcinoma. Alpha-fetoprotein levels were significantly lower in cases in which the main nodule was diagnosed to be well differentiated hepatocellular carcinoma than in other cases. The 5-year survival rate and recurrence-free survival rate were significantly greater in cases in which the main nodule showed well differentiated hepatocellular carcinoma (78.1% and 33.8%, respectively) than in other cases [moderately differentiated 49.0% (p<0.0001), 11.6% (P=0.0002); poorly differentiated 37.4% (p<0.0001), 8.3% (P=0.0002), respectively]. Multivariate analysis identified the histopathological grade of the main nodule as significant independent prognostic factors.

CONCLUSIONS

There were differences in surgical outcome in relation to the histopathological grade of differentiation of the main nodule in patients with synchronous multicentric hepatocellular carcinoma.

摘要

背景/目的:研究同步多中心肝细胞癌患者手术治疗后的临床病理特征及预后与主要结节组织病理学分化程度的关系。

方法

回顾性研究1988年至1999年间接受根治性肝切除术的265例同步多中心肝细胞癌患者(共683个结节)。在多中心发生的肝细胞癌中,将最大尺寸的肿瘤定义为主要结节,其他为附属结节。

结果

主要结节的组织病理学分化程度评估为高分化的患者有72例(27.2%),中分化的患者有160例(60.4%),低分化的患者有33例(12.4%)。高分化肝细胞癌患者主要结节的肿瘤大小明显小于中分化或低分化肝细胞癌患者。主要结节诊断为高分化肝细胞癌的病例中,甲胎蛋白水平明显低于其他病例。主要结节表现为高分化肝细胞癌的病例5年生存率和无复发生存率明显高于其他病例[中分化分别为49.0%(p<0.0001)、11.6%(P=0.0002);低分化分别为37.4%(p<0.0001)、8.3%(P=0.0002)]。多因素分析确定主要结节的组织病理学分级为显著的独立预后因素。

结论

同步多中心肝细胞癌患者手术预后与主要结节组织病理学分化程度存在差异。

相似文献

1
Histopathologic differentiation of the main nodule determines outcome after hepatic resection for synchronous multicentric hepatocellular carcinomas.主结节的组织病理学分化决定了同步多中心肝细胞癌肝切除术后的预后。
Hepatogastroenterology. 2004 Mar-Apr;51(56):500-4.
2
Patterns of and risk factors for recurrence after liver resection for well-differentiated hepatocellular carcinoma: a special reference to multicentric carcinogenesis after operation.高分化肝细胞癌肝切除术后的复发模式及危险因素:特别提及术后多中心癌变
Hepatogastroenterology. 1999 Nov-Dec;46(30):3212-5.
3
Influence of prognostic factors on the outcome of liver transplantation for hepatocellular carcinoma on cirrhosis: a univariate and multivariate analysis.预后因素对肝硬化合并肝细胞癌肝移植结局的影响:单因素和多因素分析
Hepatogastroenterology. 2004 Mar-Apr;51(56):510-4.
4
Clinicopathologic features and prognostic factors of resected solitary small-sized hepatocellular carcinoma.切除的孤立性小肝癌的临床病理特征及预后因素
Hepatogastroenterology. 2005 Jul-Aug;52(64):1163-7.
5
Risk factors of the recurrence of hepatocellular carcinoma originating from residual cancer cells after hepatectomy.肝切除术后源于残留癌细胞的肝细胞癌复发的危险因素。
Hepatogastroenterology. 1999 Jul-Aug;46(28):2469-75.
6
Accompanying liver cirrhosis as a risk factor for recurrence after resection of solitary hepatocellular carcinoma.伴有肝硬化作为孤立性肝细胞癌切除术后复发的一个危险因素。
Hepatogastroenterology. 2003 Nov-Dec;50(54):1991-5.
7
Small hepatocellular carcinoma with minute satellite nodules.伴微小卫星结节的小肝细胞癌
Hepatogastroenterology. 2000 Jul-Aug;47(34):1063-6.
8
Predictors of long-term survival after liver transplantation for hepatocellular carcinoma.肝细胞癌肝移植术后长期生存的预测因素。
Am J Gastroenterol. 2005 Dec;100(12):2708-16. doi: 10.1111/j.1572-0241.2005.00289.x.
9
Prognostic factors for hepatocellular carcinoma < or = 3 cm in diameter.直径小于或等于3厘米的肝细胞癌的预后因素
Hepatogastroenterology. 2003 Nov-Dec;50(54):2043-8.
10
Efficacy of major hepatectomy for large hepatocellular carcinoma.大肝癌肝切除术的疗效
Hepatogastroenterology. 2009 May-Jun;56(91-92):768-72.

引用本文的文献

1
Impact of antiviral therapy with nucleos(t)ide analog on survival of patients with HBV-related small hepatocellular carcinomas.核苷(酸)类似物抗病毒治疗对乙肝相关小肝细胞癌患者生存的影响。
Cancer Manag Res. 2019 Sep 17;11:8475-8486. doi: 10.2147/CMAR.S201744. eCollection 2019.
2
Prediction of histological grade of hepatocellular carcinoma using quantitative diffusion-weighted MRI: a retrospective multivendor study.使用定量扩散加权磁共振成像预测肝细胞癌的组织学分级:一项回顾性多厂商研究
Br J Radiol. 2018 Apr;91(1084):20170728. doi: 10.1259/bjr.20170728. Epub 2018 Feb 5.
3
Imaging Diagnosis of Hepatocellular Carcinoma: Recent Advances of Contrast-Enhanced Ultrasonography with SonoVue®.
肝细胞癌的影像学诊断:使用声诺维®的超声造影的最新进展
Liver Cancer. 2016 Feb;5(1):55-66. doi: 10.1159/000367748. Epub 2015 Dec 18.
4
Prediction of the histopathological grade of hepatocellular carcinoma using qualitative diffusion-weighted, dynamic, and hepatobiliary phase MRI.使用定性扩散加权、动态和肝胆期 MRI 预测肝细胞癌的组织病理学分级。
Eur Radiol. 2012 Aug;22(8):1701-8. doi: 10.1007/s00330-012-2421-6. Epub 2012 Mar 22.
5
Expressions of cysteine-rich61, connective tissue growth factor and Nov genes in hepatocellular carcinoma and their clinical significance.富含半胱氨酸蛋白61、结缔组织生长因子和Nov基因在肝细胞癌中的表达及其临床意义。
World J Gastroenterol. 2004 Dec 1;10(23):3414-8. doi: 10.3748/wjg.v10.i23.3414.